Karine Tawagi MD· @DrKarineTawagi · X·· 2 days agoScore90
Body
Full house for Bladder/RCC updates first with #KN866 #ESMO26
Gem/cis in MIBC + placebo or pembro
(➖) study & less relevance in the era of EVP SOC
Vs similar trial NIAGARA was ➕
pCR 44.4% vs 35.8%
EFS & OS not significant
We wait #VOLGA tomorrow for more in this space
1463 views · 15 likes · 3 reposts · 0 replies
Conference abstracts
LBA2matched by Presidential Symposium I
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.orgSource: Karine Tawagi MD · x.com